<DOC>
	<DOCNO>NCT01216579</DOCNO>
	<brief_summary>The investigator hypothesise titration asthma medication mannitol challenge result reduce number mild asthma exacerbation , one year , compare titration BTS guideline . To test hypothesis investigator propose primary care , parallel treatment , patient blind study match group asthmatic patient treat accordance either BTS guideline treatment algorithm dependent mannitol challenge result . Purpose study evaluate efficacy treatment algorithm base measurement airway hyperresponsiveness mannitol challenge , surrogate marker airway inflammation , long term treatment asthma comparison BTS guideline .</brief_summary>
	<brief_title>Steroid Titration Against Mannitol IN Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<criteria>Male female asthmatic age &gt; /= 16 year Females must non pregnant non lactate FEV1 &gt; /= 50 % predict Mannitol PD10 &lt; /= 635 mg end step period No recent exacerbation asthma require oral prednisolone previous 3 month Able perform technique necessary carry challenge test lung function compliant take study medication Good inhaler technique reinforce study visit Male female patient age 15 FEV1 &lt; /= 50 % predicted Patients currently take pulse oral corticosteroid Patients follow concomitant illness : bronchiectasis , allergic bronchopulmonary aspergillosis , COPD , heart failure , pulmonary fibrosis , rhinosinusitis polyp Immunocompromised patient Patients recurrent LRTI Patients document aspirin induced asthma LRTAs Pregnancy Known suspect hypersensitivity ICS excipients MDIs HIV/Hepatitis B C positive</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>